Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to assess the effect of standard versus aggressive inhibition
of the renin-angiotensin system (RAS)in type 2 diabetic patients with microalbuminuria (MA)
on; a)progression of microalbuminuria, b)estimated glomerular filtration rate (eGFR),
c)endothelial dysfunction (measured by post-hyperemia arterial tonometry) and d)the slowing
of the progression of atherosclerotic disease (measured by carotid intima media thickness
[CIMT]).